Skip to main content

Closed

VIVS: VivoSim Labs, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+32.1% / yr

Operating margin-8768.7%

ROIC-227.6%

Financially safe

Stretched

Debt / equity-0.41×

Interest coverage-957.3×

Current ratio2.38×

VivoSim Labs, Inc.

VIVSNASDAQ·USD·Closed

VivoSim Labs, Inc.

VIVSNASDAQ·USD·Closed

$0.34

−10.73%

$0.34

−$0.04 (10.73%)

52W Range

1thpctl

Volume

1.58×avg

Mkt Cap

885149USD

P/E

-0.0TTM

Div Yield

–ann

52W Range

1thpctl

Volume

1.58×avg

Market Cap

885149USD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings